Medical Equipment

Continuous Renal Replacement Therapy Market 2025–2029: Strategic Opportunities and Growth Insights

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the continuous renal replacement therapy market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Continuous Renal Replacement Therapy Market Now And By 2029?

The continuous renal replacement therapy market size has experienced rapid growth in recent years. It is projected to expand from $1.57 billion in 2024 to $1.73 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.5%. This historic period of growth can be ascribed to several factors, including an increased demand for advanced CRRT devices, a rising prevalence and incidence of acute kidney injury, an expansion in the number of medical applications, a significant prevalence of co-morbidities, and ongoing research and development initiatives.

The market size for continuous renal replacement therapy is poised for significant expansion in the coming years. It is projected to climb to $2.55 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.2%. This expected growth during the forecast period can be attributed to an increase in the incidence of chronic kidney diseases, the rising prevalence of diabetes, a growing volume of ICU admissions, augmented investments in healthcare infrastructure, and the widening application of these therapies in pediatric care. Prominent trends throughout this period will include swift advancements, the introduction of new technologies, ongoing technological improvements, product innovation, and the development of technologically advanced CRRT products.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15777&type=smp

Which Long-Term Drivers Are Expected To Sustain The Continuous Renal Replacement Therapy Market?

The continuous renal replacement therapy market is anticipated to expand due to the increasing prevalence of chronic kidney diseases. Chronic kidney disease (CKD) is a persistent ailment where the kidneys gradually lose their ability to function over time, leading to insufficient filtration of waste products from the blood. The rising number of chronic kidney disease cases is influenced by factors such as lifestyle changes, an aging population, and increased rates of diabetes and hypertension. Continuous renal replacement therapy is employed in chronic kidney disease patients for acute flare-ups or complications, aiding in fluid balance management and the consistent removal of metabolic waste products. For example, in May 2024, the Centers for Disease Control and Prevention, a U.S.-based national public health agency, reported that over 1 in 7 adults in the US, amounting to more than 35.5 million people, are estimated to have chronic kidney disease (CKD). Alarmingly, nearly 90% of these individuals are unaware of their condition, revealing a substantial gap in early detection and awareness efforts for CKD in the US. Thus, the growing incidence of chronic kidney diseases is a primary driver for the expansion of the continuous renal replacement therapy market.

How Is The Continuous Renal Replacement Therapy Market Classified By Different Segments?

The continuous renal replacement therapymarket covered in this report is segmented –

1) By Product: System, Consumables

2) By Therapy: Renal, Non-Renal

3) By Modality: Slow Continuous Ultra-Filtration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), Continuous Venovenous Hemodiafiltration (CVVHDF)

4) By Age Group: Adults, Pediatrics Or Neonates

5) By End-Users: Hospitals, Ambulatory Care, Homecare

Subsegments:

1) By System: Hemofilters, CRRT Machines, Blood Tubing Sets

2) By Consumables: Dialysate Solutions, Replacement Fluids, Catheters, Bloodline Sets

What Current And Upcoming Trends Are Shaping The Continuous Renal Replacement Therapy Market?

Leading companies in the continuous renal replacement therapy market are directing their efforts towards developing innovative renal therapy options for dialysis patients to enhance treatment efficacy, improve patient outcomes, and reduce complications associated with traditional dialysis methods. This advanced therapy functions continuously, typically over 24 hours, and is less taxing on the body compared to standard dialysis, making it suitable for patients with acute kidney injuries or severe health conditions. For instance, in January 2023, a report published by Peconic Bay Medical Center (PBMC), a US-based medical center that provides medical services including emergency care and surgical services, announced the launch of a new renal therapy option for dialysis patients. The therapy is crafted to be more comfortable for patients who may not tolerate standard dialysis due to their medical conditions. CRRT is administered more slowly than traditional dialysis, which helps minimize stress on critically ill patients.

Who Are The Primary Market Leaders In The Continuous Renal Replacement Therapy Market?

Major companies operating in the continuous renal replacement therapy market are Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, NxStage Medical Inc., Hillrom Holdings Inc., Gambro AB, JMS Co. Ltd., Quanta Dialysis Technologies Ltd., Bellco S.r.l., Ningbo Tianyi Medical Devices Co. Ltd., Cytosorbents Corporation, Kawasumi Laboratories Inc., Medica S.p.A., Infomed SA, Medites Pharma Spol. S.R.O, Nikkiso Co. Ltd., Anjue Medical Equipment Co. Ltd., Medcomp Systems Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/continuous-renal-replacement-therapy-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Continuous Renal Replacement Therapy Market?

North America was the largest region in the continuous renal replacement therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15777&type=smp

Browse Through More Reports Similar to the Global Continuous Renal Replacement Therapy Market 2025, By The Business Research Company

Coronavirus Current Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/coronavirus-current-therapy-global-market-report

Plasmas Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Tumor Ablation Therapy Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795